Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)

PHASE2RecruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2033

Conditions
High Risk Prostate Carcinoma
Interventions
RADIATION

Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients

this researcher performed biodegradable material injection during radical radiotherapy in combination with hormone therapy in high - risk prostate cancer patients. after subdivision radical received radiation therapy We plan to conduct a phase II clinical study to evaluate the safety of prostate cancer patients.

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER